SecBot SecBot
Insider Cluster (2 insiders) ·Filed Apr 9, 2026

BLTE

BELITE BIO, INC
BEARISH
Impact 6/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $812K total
Actionable Insight ▼ Bearish

Monitor for upcoming earnings or regulatory updates; coordinated C-suite selling at a material dollar level may precede negative news or reflect profit-taking after a run-up. Compare to historical patterns — if this is an outlier, it could signal caution.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
BLTE ▼ -14.99% at T+60d
SHORT call ✓ call won +14.99% · α vs SPY +25.77% · entry $181.17 → $154.02
Entry = T+0 close
Apr 8, 2026
via day close
T+1d
-4.64%
call +4.64% · α +4.58%
$172.76
settled 7mo ago
T+5d
-12.76%
call +12.76% · α +15.95%
$158.05
settled 6mo ago
T+20d
-13.78%
call +13.78% · α +21.34%
$156.21
settled 6mo ago
T+60d
-14.99%
call +14.99% · α +25.77%
$154.02
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Two C-suite executives at Belite Bio sold shares in a coordinated 7-day window, totaling $812K in open-market transactions. CEO Lin Yu-Hsin and CFO Chuang Hao-Yuan both sold shares near $180.35, signaling potential lack of confidence in near-term valuation.

Key Financial Metrics

Direction
selling
Total Value
$811.6K
Insiders
2

Key Facts

  • CEO Lin Yu-Hsin sold 2,500 shares at $180.36, totaling $451K in open-market sale
  • CFO Chuang Hao-Yuan sold 2,000 shares at $180.35, totaling $361K in open-market sale
  • Total insider selling cluster value: $812K over 7 days
  • Both transactions were open-market sales (code 'S'), not routine non-cash events
  • Market cap: $6.8B; total selling represents 0.012% of market cap

Financial Impact

$812,000 in net insider selling by two C-suite executives

insider ownershipinvestor sentiment

Risk Factors

  • Potential perception of insider pessimism ahead of earnings or clinical data readout
  • Risk of short-term downward pressure on stock if retail investors interpret selling as negative signal

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BLTE-1776111352458
11 reports for BLTE
Performance horizon
71% Hit rate @ T+20 5 of 7 directional calls Went positive at some point 6 of 7 best @ T+60▲ +26.98%Jun 12, 2026
Filters
Rows
Reports for BLTE — sortable, filterable
TypeNow
Oct 19, 2026
7d ago
6-K
NEUTRAL ★ 4/10
$147.34awaiting T+20—$147.33 (−0.01%)
Sep 9, 2026
6w ago
Insider Cluster
BEARISH ★ 6/10
$175.07 $152.52▲ +12.88%▲ +15.01%$147.33 (+15.85%)
Aug 12, 2026
10w ago
6-K
BULLISH ★ 7/10
$166.28 $173.79▲ +4.52%▲ +6.26%$147.33 (−11.40%)
Aug 12, 2026
10w ago
Press Release
BULLISH ★ 7/10
$166.28 $173.79▲ +4.52%▲ +6.26%$147.33 (−11.40%)
Jun 12, 2026
19w ago
6-K
BULLISH ★ 6/10
$144.24 $147.03▲ +1.93%▲ +2.68%$147.33 (+2.14%)
May 20, 2026
22w ago
Press Release
MIXED ★ 6/10
$143.36 $146.12▲ +1.93%▲ +1.18%$147.33 (+2.77%)
Apr 21, 2026
26w ago
6-K
BULLISH ★ 8/10
$167.42 $139.70▼ −16.56%▼ −19.72%$147.33 (−12.00%)
Apr 21, 2026
26w ago
Press Release
NEUTRAL ★ 5/10
$167.42 $139.70▼ −16.56%▼ −19.72%$147.33 (−12.00%)
Apr 9, 2026
28w ago
Insider Cluster
BEARISH ★ 7/10
$181.17 $156.21▲ +13.78%▲ +21.34%$147.33 (+18.68%)
Apr 9, 2026
28w ago
Insider Cluster
BEARISH ★ 6/10
$181.17 $156.21▲ +13.78%▲ +21.34%$147.33 (+18.68%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 13, 2026